Cancer Cell Int
From Bioblast
Revision as of 15:41, 10 December 2019 by Plangger Mario (talk | contribs) (Created page with "{{Journal |Title=[https://cancerci.biomedcentral.com/ Cancer Cell International] }}")
Journal title and website | Cancer Cell International |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Wang 2023 Cancer Cell Int | Wang Y, Wang J, Chen L, Chen Z, Wang T, Xiong S, Zhou T, Wu G, He L, Cao J, Liu M, Li H, Gu H (2023) PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis. https://doi.org/10.1186/s12935-023-03178-0 | 2023 | Cancer Cell Int 23:323. PMID: 38102641 Open Access |
Shim 2022 Cancer Cell Int | Shim JK, Choi S, Yoon SJ, Choi RJ, Park J, Lee EH, Cho HJ, Lee S, Teo WY, Moon JH, Kim HS, Kim EH, Cheong JH, Chang JH, Yook JI, Kang SG. (2022) Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres. Cancer Cell Int 22:309. | 2022 | PMID:36221088 Open Access |
Sharma 2021 Cancer Cell Int | Sharma P, Sharma V, Ahluwalia TS, Dogra N, Kumar S, Singh S (2021) Let-7a induces metabolic reprogramming in breast cancer cells via targeting mitochondrial encoded ND4. Cancer Cell Int 21:629. | 2021 | PMID: 34838007 Open Access |
Gao 2019 Cancer Cell Int | Gao Y, Dorn P, Liu S, Deng H, Hall SRR, Peng RW, Schmid RA, Marti TM (2019) Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment. Cancer Cell Int 19:317. | 2019 | PMID: 31798346 Open Access |